Immunovant Overview
Immunovant Target Price
Analysts' 12-month price predictions for IMVT.
Get informed when a big investor buys or sells
+ FollowShare Price
$37.62
Average Target Price
$40.00
6.3% upside
6.3% upside1 analysts in the last 4 months
High: $40 | Low: $40
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-21 | H.C. WainwrightDouglas Tsao | $40 | 6.3% upside |  |
| 2026-01-06 | Wolfe Research | $50 | 32.9% upside | |
| 2025-12-18 | GuggenheimYatin Suneja | $41 | 9% upside | |
| 2025-10-14 | Truist Financial | $16 |  57.5% downside | |
| 2024-09-10 | H.C. WainwrightDouglas Tsao | $51 | 35.6% upside | |
| 2024-06-03 | OppenheimerLeland Gershell | $46 | 22.3% upside | |
| 2024-05-30 | GuggenheimYatin Suneja | $48 | 27.6% upside | |
| 2024-05-30 | Piper SandlerYasmeen Rahimi | $57 | 51.5% upside | |
| 2024-03-13 | Goldman SachsCorinne Johnson | $50 | 32.9% upside | |
| 2022-09-26 | UBSColin Bristow | $5 | 86.7% downside | |